首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1490016

藥物基因體學市場：按技術、按應用、按最終用戶、按地區

Pharmacogenomics Market, By Technology, By Application, By End User By Geography

出版日期: 2024年04月30日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年全球藥物基因體學市場規模估計為171.9億美元，預計2031年將達373.2億美元，2024年至2031年年複合成長率為11.7%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	171.9億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測2024-2031年年複合成長率：	11.70%	2031年價值預測	373.2億美元

圖：2024年依地區分類的藥物基因體學市場佔有率（%）

藥物基因體學是分析基因如何影響人類對藥物反應的科學分支。基於這樣的原理：每個人的基因組成都會影響身體的代謝和對藥物的反應。隨著基因篩檢和測試技術的進步，藥物基因體學目的是開發考慮患者個體遺傳特徵的個人化處方方法。這樣可以根據患者的獨特需求選擇有效的藥物，同時減少試驗試驗和副作用。隨著越來越多的醫療保健系統意識到這種方法在最佳化藥物治療結果方面的臨床效用，全球藥物基因體學市場預計在未來幾年將顯著成長。

市場動態：

全球藥物基因體學市場受到副作用發生率增加、個人化醫療需求增加以及伴同性診斷的普及等因素的推動。製藥公司利用藥物基因體學方法開發標靶治療的研發成本不斷上升，也推動了市場成長。然而，基因檢測缺乏臨床檢驗和標準化是阻礙其在臨床上普及的問題。與基因篩檢相關的資料隱私和道德問題進一步阻礙了市場擴張。將藥物基因體學測試和分析納入藥物臨床試驗和監管核准流程中存在機會。開拓負擔得起的藥物遺傳學診斷套件和服務也是市場成長的一個途徑，特別是在普及緩慢的新興市場。

本研究的主要特點

本報告對全球藥物基因學市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
強調了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球藥物基因體學市場的主要企業。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球藥物基因體學市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球藥物基因體學市場時所使用的各種策略矩陣來促進決策。

公司簡介
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Pharmigene
- Abbott
- Agilent Technologies, Inc.
- QIAGEN
- GE HealthCare
- Empire Genomics, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies plc.
- PerkinElmer Inc.
- Myriad Genetics, Inc.
- Illumina, Inc.
- Macrogen, Inc.
- BGI Genomics
- Eurofins Scientific
- MapMyGenome
- Invitae Corporation

第10章分析師觀點

Wheel of Fortune
分析師觀點
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1053

The global pharmacogenomics market is estimated to be valued at USD 17.19 Bn in 2024 and is expected to reach USD 37.32 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 17.19 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	11.70%	2031 Value Projection:	US$ 37.32 Bn

Figure. Pharmacogenomics Market Share (%), By Region, 2024

Pharmacogenomics is the branch of science that analyzes how genes affect a person's response to medications. It works on the principle that each person's genetic make-up can influence how their body metabolizes and responds to drugs. With advancements in genetic screening and testing technologies, pharmacogenomics aims to develop personalized prescription approaches that factor in patients' individual genetic profiles. This enables the selection of effective medicines tailored to patients' specific needs while reducing trial-and-error prescribing practices and adverse drug reactions. The global pharmacogenomics market is expected to grow significantly in the coming years as more healthcare systems recognize the clinical utility of this approach in optimizing pharmacotherapy outcomes.

Market Dynamics:

The global pharmacogenomics market is driven by factors such as rising incidences of adverse drug reactions, growing need for personalized medicine, and increasing uptake of companion diagnostics. High research and development expenditures by pharmaceutical companies to develop targeted therapies using pharmacogenomics approaches are also fueling the market growth. However, lack of clinical validation and standardization of genetic tests remains a challenge limiting widespread clinical adoption. Data privacy and ethical concerns related to genetic screening further hamper market expansion. Opportunities lie in incorporating pharmacogenomic testing and profiling into drug trials and regulatory approval processes. Developing affordable pharmacogenetic diagnostic kits and services especially for underpenetrated emerging markets also presents an avenue for market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global pharmacogenomics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pharmacogenomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pharmigene, Abbott, Agilent Technologies, Inc., QIAGEN, GE HealthCare, Empire Genomics, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies plc., PerkinElmer Inc. , Myriad Genetics, Inc., Illumina, Inc., Macrogen, Inc. , BGI Genomics, Eurofins Scientific, MapMyGenome, and Invitae Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global pharmacogenomics market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacogenomics market.

Detailed Segmentation-

By Technology:
- DNA Sequencing
- Microarray
- Polymerase Chain Reaction
- Electrophoresis
- Mass Spectrometry
- Others
By Application:
- Cardiovascular Diseases
- Infectious Diseases
- Oncology
- Neurological Diseases
- Pain Management
- Others
By End User:
- Hospitals & Clinics
- Research Institutions and Academic Institutes
- Diagnostic Laboratories
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd
- Pharmigene
- Abbott
- Agilent Technologies, Inc.
- QIAGEN
- GE HealthCare
- Empire Genomics, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies plc.
- PerkinElmer Inc.
- Myriad Genetics, Inc.
- Illumina, Inc.
- Macrogen, Inc.
- BGI Genomics
- Eurofins Scientific
- MapMyGenome
- Invitae Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Pharmacogenomics Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Pharmacogenomics Market, By Technology, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
DNA Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microarray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Polymerase Chain Reaction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Electrophoresis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Mass Spectrometry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Pharmacogenomics Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurological Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Pharmacogenomics Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research Institutions and Academic Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Pharmacogenomics Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-La Roche Ltd
- Pharmigene
- Abbott
- Agilent Technologies, Inc.
- QIAGEN
- GE HealthCare
- Empire Genomics, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies plc.
- PerkinElmer Inc.
- Myriad Genetics, Inc.
- Illumina, Inc.
- Macrogen, Inc.
- BGI Genomics
- Eurofins Scientific
- MapMyGenome
- Invitae Corporation